M-A | 5-alpha-reductase inhibitors are not associated with increased risk of mortality from prostate cancer

Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality: A Systematic Review and Meta-analysis – JAMA Oncology (free for a limited period)

Commentary on Twitter

Systematic review & meta-analysis drawing on 2 decades of epidemiologic literature and including data from over 3 million patients shows no significant association between use of 5-alpha reductase inhibitor use and mortality from prostate cancer. https://t.co/3l9jT1l2P9 #PCSM

— JAMA Oncology (@JAMAOnc) April 21, 2023